Prof. Amitis Ramezani | Vaccination | Best Researcher Award

Published on by Infectious

Prof. Amitis Ramezani | Vaccination | Best Researcher Award

Prof. Amitis Ramezani | Vaccination - Pasteur Institute of Iran, Iran

Professor Amitis Ramezani is a distinguished figure in infectious diseases with a strong emphasis on Vaccination. Her dedication to public health has shaped vaccination research, vaccination awareness, vaccination policy, and vaccination delivery. Known for her vaccination expertise, she has led vaccination programs, vaccination evaluations, and vaccination safety studies. Her contributions to vaccination epidemiology, vaccination outcomes, and vaccination trials are notable. Ramezani's influence in vaccination communication, vaccination surveillance, and vaccination education is profound. With a career rooted in vaccination, she continues to advance vaccination innovation, vaccination strategy, and vaccination outreach. Her scholarly work enriches vaccination literature, promotes vaccination efficiency, and addresses vaccination concerns. Professor Ramezani is a leading voice in the global vaccination dialogue.

Academic Profile

ORCID 

EDUCATION

Professor Amitis Ramezani pursued her education with a strong focus on Vaccination. From her MD to specialization in infectious diseases, she integrated vaccination theories, vaccination modules, and vaccination science into her academic training. At Tehran University, vaccination epidemiology and vaccination safety guided her studies. Her MPH training emphasized vaccination impact, vaccination ethics, and vaccination outreach. Throughout her education, vaccination preparedness, vaccination risk analysis, and vaccination immunity were recurring themes. Her research projects included vaccination trials, vaccination reporting, and vaccination modeling. She aligned her educational goals with global vaccination standards, focusing on vaccination optimization and vaccination sustainability. Ramezani’s academic background underscores her lifetime commitment to advancing the field of Vaccination.

PROFESSIONAL EXPERIENCE

Amitis Ramezani’s professional trajectory is defined by her leadership in Vaccination. She has led vaccination projects, vaccination coordination teams, and vaccination safety initiatives. At the Pasteur Institute of Iran, she supervised vaccination surveillance, vaccination data analysis, and vaccination policy reviews. Ramezani’s committee roles focused on vaccination monitoring, vaccination risk-benefit evaluations, and vaccination adverse effect investigations. With responsibilities across vaccination implementation, vaccination campaign assessments, and vaccination coverage studies, she shaped national strategies. She contributed to vaccination rollout planning, vaccination incident reporting, and vaccination equity. Her service includes oversight of vaccination trials and fostering multidisciplinary collaboration to ensure Vaccination remains a public health priority.

RESEARCH INTEREST

Vaccination stands at the center of Professor Ramezani’s research interests. Her work includes vaccination immunity, vaccination side effect monitoring, and vaccination coverage evaluation. Ramezani investigates vaccination technology transfer, vaccination in vulnerable populations, and long-term vaccination effects. Her ongoing studies address vaccination resistance, vaccination schedule optimization, and post-vaccination syndromes. She examines vaccination immunogenicity, vaccination antibodies, and vaccination challenges in chronic diseases. Her findings enhance vaccination policy, vaccination preparedness, and vaccination education. With over 30 vaccination-related projects, her efforts push boundaries in vaccination efficiency, vaccination innovation, and vaccination standardization. Her scientific inquiry consistently enhances the field of Vaccination through rigorous investigation and analysis.

AWARDS AND HONORS

Professor Ramezani has received recognition for her lifelong dedication to Vaccination. Her accolades highlight excellence in vaccination research, vaccination education, and vaccination innovation. She has been honored for her role in vaccination trial success, vaccination equity initiatives, and vaccination health promotion. Acknowledged by international bodies, her awards reflect achievements in vaccination safety, vaccination monitoring, and vaccination access. She earned distinctions in vaccination campaign leadership, vaccination community engagement, and vaccination protocol development. Her service in vaccination committees, vaccination panels, and vaccination outreach has further solidified her status. Every award she receives reinforces her unwavering impact in the sphere of Vaccination.

RESEARCH SKILLS

Ramezani demonstrates vast research skills centered on Vaccination. She excels in vaccination study design, vaccination cohort analysis, and vaccination efficacy trials. Her skills include managing vaccination databases, conducting vaccination serology, and performing vaccination immunogenicity profiling. She’s adept in vaccination protocol development, vaccination modeling, and vaccination bioinformatics. She leads vaccination monitoring programs, vaccination adverse event reviews, and post-vaccination surveys. Her techniques span vaccination safety evaluation, vaccination trial logistics, and vaccination effectiveness measurement. She continually hones her expertise in vaccination study metrics, vaccination case follow-up, and vaccination field implementation. Her methodological strength ensures high standards in every Vaccination research initiative she leads.

PUBLICATIONS

Professor Ramezani has published extensively on Vaccination. Her work spans vaccination outcomes, vaccination durability, and vaccination safety profiles. Notably, her peer-reviewed articles explore vaccination technology, vaccination antibody response, and vaccination clinical trials. Each publication emphasizes vaccination timelines, vaccination performance, and vaccination-induced immunity. She has authored research on vaccination in special populations, vaccination hesitancy, and vaccination follow-up. Her findings support improved vaccination strategy, vaccination effectiveness, and vaccination readiness. Journals cite her vaccination frameworks, vaccination response models, and vaccination data. With over 100 articles, she contributes significantly to global understanding of Vaccination, informing best practices and influencing vaccination discourse worldwide.

  • Title: Nasopharyngeal Carriage, Serotype Distribution, and Antimicrobial Susceptibility of Streptococcus pneumoniae Among PCV13-Vaccinated and -Unvaccinated Children in Iran
    Authors: Fatemeh Ashrafian; Mona Sadat Larijani; Saiedeh Haji Maghsoudi; Delaram Doroud; Alireza Fahimzad; Zahra Pournasiri; Elham Jafari; Masoumeh Parzadeh; Sara Abdollahi; Elham Haj Agha Gholizadeh Khiavi et al.
    Journal: Vaccines

 

  • Title: Circulatory microRNAs as potential biomarkers for different aspects of COVID-19
    Authors: Mahsan Zali; Mona Sadat Larijani; Anahita Bavand; Ladan Moradi; Fatemeh Ashrafian; Amitis Ramezani
    Journal: Archives of Virology

 

  • Title: Manifestations, complications, and treatment of neurobrucellosis: a systematic review and meta-analysis
    Authors: Amin Tajerian; Masoomeh Sofian; Nader Zarinfar; Amitis Ramezani
    Journal: International Journal of Neuroscience

 

  • Title: Long-term rheumatoid manifestations as a consequence of COVID-19 and/or vaccination: A case report after a 2-year follow-up
    Authors: Mona Sadat Larijani; Mohammad Banifazl; Afsaneh Karami; Amitis Ramezani
    Journal: Heliyon

 

  • Title: The impact of ABO blood types on humoral immunity responses and antibody persistency after different COVID‐19 vaccine regimens
    Authors: Mona Sadat Larijani; Amir Javadi; Seyed Ebrahim Eskandari; Delaram Doroud; Fatemeh Ashrafian; Mohammad Banifazl; Ali Khamesipour; Anahita Bavand; Amitis Ramezani
    Journal: Journal of Medical Virology

 

  • Title: Assessment of COVID‐19 Vaccine Impact on Women’s Menstrual Health within an 18‐Month Follow‐Up
    Authors: Mona Sadat Larijani; Sana Eybpoosh; Delaram Doroud; Anahita Bavand; Ladan Moradi; Fatemeh Ashrafian; Parinaz Tajmehrabi Namini; Mahsan Zali; Amitis Ramezani; Süleyman Cemil Oğlak
    Journal: Obstetrics and Gynecology International

CONCLUSION

Professor Amitis Ramezani’s career is a testament to dedication in the field of Vaccination. Her impact spans vaccination science, vaccination policy, and vaccination practice. Through her work, vaccination protocols have evolved, vaccination confidence has increased, and vaccination access has improved. She continues to influence vaccination research, vaccination policymaking, and vaccination capacity building. Her legacy is reflected in vaccination awareness, vaccination inclusivity, and vaccination development. She stands as a global advocate for Vaccination, promoting rigorous standards in vaccination trial ethics, vaccination education, and vaccination implementation. Professor Ramezani exemplifies commitment, innovation, and leadership—anchored firmly in the science and service of Vaccination.

Dr. Dereje Bayissa Demissie | malaria | Best Researcher Award

Published on by Infectious

Dr. Dereje Bayissa Demissie | malaria | Best Researcher Award

Dr. Dereje Bayissa Demissie | malaria - Stellenbosch University, Faculty of Medicine and Health Sciences,Ethiopia

Dr. Dereje Bayissa Demissie is a renowned public health expert with malaria expertise rooted deeply in academia and field research. His malaria-focused contributions, including systematic reviews and malaria control studies, have profoundly influenced health strategies. Through his malaria investigations, Dr. Demissie shaped policies around reproductive health and digital health. The malaria research led by Dr. Demissie spans decades, showcasing consistent malaria innovation and malaria commitment. He presents malaria at global conferences, where malaria remains a central discussion. His malaria work earned him prestigious recognitions, proving malaria dedication. With over 50 publications mentioning malaria and his leadership in malaria programs, Dr. Demissie is a global name associated with transformative malaria impact across Africa and beyond.

AUTHOR PROFILE

ORCID | GOOGLE SCHOLAR

EDUCATION

Dr. Demissie’s malaria academic journey spans from a BSc in Nursing to a PhD in Health Studies, always keeping malaria at the core. His malaria training involved institutions like Haramaya, Jimma, Addis Ababa, and UNISA. Each malaria academic pursuit fortified his malaria research interest. The malaria curriculum at these institutions included modules on malaria epidemiology and malaria intervention strategies. During his malaria thesis work, Dr. Demissie examined malaria healthcare outcomes, malaria patient management, and malaria data systems. His education is malaria-aligned with global malaria knowledge standards. His consistent malaria specialization shaped his malaria research and malaria publication legacy, making him a distinguished scholar in malaria policy and malaria education.

PROFESSIONAL EXPERIENCE

Dr. Demissie’s malaria experience spans over 14 years in malaria research, malaria academic roles, and malaria health system strengthening. He held malaria-driven positions at institutions such as SPHMMC, Ambo University, and Stellenbosch. In every role, malaria was prioritized—whether teaching malaria modules or conducting malaria implementation science. He led malaria teams, advised malaria policy boards, and participated in malaria evaluation missions. His malaria efforts were embedded in multidisciplinary projects, always integrating malaria surveillance and malaria control methods. As a postdoctoral fellow, malaria intervention impact is a key research aim. Dr. Demissie’s career exemplifies a professional journey grounded in malaria excellence and malaria transformation.

RESEARCH INTEREST

Dr. Demissie’s research orbit revolves around malaria with thematic expansions to digital health, maternal care, and reproductive health—always tethered to malaria dynamics. His malaria interests involve malaria burden estimation, malaria diagnostics, and malaria preventive strategies. He explores malaria in vulnerable populations, focusing on malaria in pregnancy, malaria comorbidities, and malaria mental health intersections. His malaria modeling work supports malaria decision-making. He assesses malaria implementation frameworks and malaria integration with digital tools. Dr. Demissie continues to evolve his malaria inquiry with advanced malaria methodologies, positioning malaria at the heart of Africa’s research agenda. He envisions malaria eradication through rigorous, community-centered malaria innovations.

AWARD AND HONOR

Dr. Demissie has been recognized with awards driven by his malaria excellence. Notably, the Unisa Principal's Award in 2024 honored his malaria research portfolio. In 2021, he received St. Paul’s Best Researcher Award, where malaria studies formed a major segment. These malaria achievements underscore his malaria impact and malaria dedication. His malaria recognitions stem from national and international bodies valuing consistent malaria output. Malaria publication metrics, malaria grant wins, and malaria mentorship records contributed to his malaria acclaim. As a malaria champion, Dr. Demissie’s award citations heavily reference malaria, cementing his stature as an exemplary malaria scientist and malaria policy influencer.

RESEARCH SKILL

Dr. Demissie excels in malaria research skills including malaria data analytics, malaria impact modeling, malaria qualitative studies, and malaria quantitative tools. He utilizes malaria platforms such as RedCap, SPSS, STATA, and EpiData for malaria investigations. His malaria statistical capacity supports malaria cohort tracking and malaria intervention evaluation. His malaria skillset includes systematic malaria reviews and malaria meta-analysis designs. Dr. Demissie’s malaria methodology proficiency ensures malaria research reliability and malaria policy uptake. He regularly trains teams in malaria sampling and malaria evidence synthesis. His malaria publication process includes malaria peer-review editing, malaria manuscript assessments, and malaria-focused journal leadership roles.

PUBLICATIONS

Dr. Demissie authored over 64 peer-reviewed works, many focused directly on malaria. His malaria papers examine long-lasting insecticidal nets, malaria in maternal populations, and malaria behavioral studies. He’s contributed malaria systematic reviews and malaria clinical trials that shape malaria control discourse. His malaria works are indexed in high-impact journals, and malaria is a keyword in nearly every publication. He authored malaria chapters and malaria reports cited globally. His malaria bibliometric record includes hundreds of malaria citations. Each malaria study by Dr. Demissie pushes forward malaria understanding, contributing substantially to malaria reduction and malaria policy enhancement across sub-Saharan Africa.

  • Title: Poor radiological outcomes and associated factors among tibial shaft fracture patients treated with intramedullary nail fixation at Addis Ababa Burn, Emergency and Trauma Hospital, Ethiopia
    Authors: Shugie, Y.; Kebede, S.; Adugna, F.; Demissie, D.B.; Desta, T.
    Journal: Frontiers in Surgery

  • Title: Prevalence of ventilator-associated pneumonia and associated factors among intubated adult patients admitted in public hospitals in Addis Ababa, Ethiopia: a facility-based retrospective study design
    Authors: Estibel Mengist Tegegne; Birhanu Chekol Gete; Dereje Bayissa Demissie
    Journal: Frontiers in Medicine

  • Title: Attitude towards assisted reproductive technology: acceptance of donors eggs, sperms, and embryos as treatment of human infertility: a systematic review and meta-analysis
    Authors: Demissei, D.B.; Biratu, T.D.; Gamshe, E.N.; Deressa, A.T.
    Journal: Reproductive Health

  • Title: Intensive Care Unit Dialysis Practice, Clinical Outcomes, and Associate Factors Among Critically Ill Patients at St.Paul’s Hospital Millennium Medical College in Addis Ababa, Ethiopia: A Prospective Cohort Study Design
    Authors: Getahun, Z.; Demissie, D.B.; Sulan, M.; Tufa, M.K.; Laytin, A.; Mehari, M.
    Journal: Research Square

  • Title: Magnitude, disparity, and predictors of poor-quality antenatal care service: A systematic review and meta-analysis
    Authors: Demissie, D.B.; Molla, G.; Tiruneh Tiyare, F.; Badacho, A.S.; Tadele, A.
    Journal: SAGE Open Medicine

CONCLUSION

In conclusion, Dr. Demissie is a malaria thought leader whose malaria scholarship, malaria education, and malaria interventions leave an enduring impact. His malaria experience spans local malaria challenges to global malaria frameworks. Dr. Demissie remains committed to malaria excellence—mentoring malaria researchers, publishing malaria science, and advising malaria strategies. His malaria contributions are embedded in the broader landscape of global health. With malaria positioned as a pressing issue, Dr. Demissie’s role in malaria discourse is increasingly vital. He envisions a malaria-free world driven by informed malaria actions, rigorous malaria research, and inclusive malaria policies. Dr. Demissie’s legacy is a malaria legacy.

Dr. Amos Kipkorir Langat | Global Health | Best Researcher Award

Published on by Infectious

Dr. Amos Kipkorir Langat | Global Health | Best Researcher Award

Dr. Amos Kipkorir Langat | Global Health - Jomo Kenyatta University of Agriculture and Technology,Kenya

Dr. Amos Kipkorir Langat is a visionary academic with a dynamic presence in Global Health research. His extensive work in mathematics, statistics, and epidemiology has catalyzed significant advancements in Global Health. Dr. Langat's expertise in Global Health modeling, infectious disease analytics, and climate-health intersections has made him a cornerstone in Global Health innovation. His teaching roles, supervisory leadership, and scholarly collaborations are deeply rooted in improving Global Health systems. Through interdisciplinary approaches, Dr. Langat continuously addresses pressing Global Health issues, offering policy and research-driven solutions. His impactful presence in Global Health spans academia, government advisory, and international workshops. Dr. Langat’s career stands as a beacon of commitment to solving complex Global Health challenges with statistical rigor.

AUTHOR PROFILE 

ORCID | GOOGLE SCHOLAR

EDUCATION

Dr. Langat’s academic path reflects a deep investment in Global Health. Earning his PhD in Mathematics (Statistics) from PAUSTI, with a Master’s in Applied Statistics and a Bachelor’s in Economics and Mathematics, he forged a trajectory toward solving Global Health issues using statistical methodologies. Each degree enhanced his capability to tackle complex Global Health problems through quantitative reasoning. His studies provided foundational knowledge vital to the analysis and modeling of Global Health patterns. Global Health implications were a central focus of his academic research and thesis work. His education consistently intersected with Global Health challenges, equipping him with skills to perform predictive modeling and health-based risk assessments vital to Global Health development.

PROFESSIONAL EXPERIENCE

Dr. Langat’s professional journey is a testament to his unwavering dedication to Global Health. As Head of the Centre for Climate Epidemic and Mathematical Innovation at PAUSTI, he integrates Global Health frameworks with mathematical modeling. His lectureship at JKUAT and previous positions at Maasai Mara and Kabarak University further expanded his impact on Global Health education. As a senior economist with the County Government of Bomet, he has advanced evidence-based policy grounded in Global Health data analytics. Across academia, administration, and public service, Global Health has remained the core theme. Through grant-funded projects, he supports African scholars in Global Health domains, nurturing a new generation of experts focused on Global Health equity.

RESEARCH INTEREST

Dr. Langat's research revolves around enhancing Global Health through statistical innovation. His focus on infectious disease modeling, Bayesian analysis, survival analysis, and environmental health positions him at the forefront of Global Health research. He applies functional and time-series analysis to derive actionable insights into critical Global Health trends. From maternal health to air pollution and COVID-19 transmission, each research angle aims to strengthen Global Health systems. His interdisciplinary investigations align mathematics with practical Global Health outcomes, promoting sustainable solutions. His interest in modeling HIV risk exposures and child survival statistics directly addresses Global Health priorities. Through his work, Global Health continues to benefit from advanced mathematical methodologies and evidence-led strategies.

AWARD AND HONOR

Dr. Langat has earned numerous accolades acknowledging his commitment to Global Health. Awarded the prestigious Pan African University PhD scholarship, his research focus on statistics consistently intersected with Global Health modeling. A postgraduate scholarship from the Higher Education Loan Board further propelled his Global Health studies. He has received grants from SICSS and the African Union, all directed toward Global Health and epidemiological research. These honors recognize his scholarly rigor and his strategic use of data science in Global Health innovation. As a recipient of these awards, Dr. Langat remains a critical contributor to Global Health capacity building in Africa. Each recognition reinforces his devotion to elevating Global Health research standards.

RESEARCH SKILL

Dr. Langat brings a vast repertoire of research skills centered on Global Health solutions. He is proficient in Bayesian modeling, time-series forecasting, spatial epidemiology, and multilevel regression—all tailored for Global Health applications. His technical command of tools like STATA, R, SPSS, and Python allows him to analyze massive Global Health datasets. Through modeling infectious diseases, climate-health linkages, and health system inefficiencies, he elevates Global Health analytics. His mastery in measurement error correction and hierarchical modeling further enhances Global Health projections. His skills empower decision-makers with real-time insights for Global Health interventions. Each statistical tool in his arsenal contributes to addressing urgent Global Health disparities across diverse populations.

PUBLICATIONS

Dr. Langat has authored over 30 impactful publications on Global Health. His studies cover topics like COVID-19 impact, maternal health, air pollution, child survival, and spatial regression—all centered on enhancing Global Health understanding. Journals like Scientific African, Asian Journal of Probability and Statistics, and Annals of Medicine and Surgery have featured his Global Health research. His work on infectious diseases, Bayesian modeling, and data-driven interventions supports critical decision-making in Global Health policy. Many articles are collaborative efforts with international researchers, reinforcing Global Health knowledge networks. Each publication advances the field of Global Health by transforming complex data into actionable public health solutions rooted in mathematical precision.

  • Title: Spatial epidemiology based on the analysis of COVID-19 in Africa
    Authors: Joyce Akhalakwa Mukolwe, John Kamwele Mutinda, Amos Kipkorir Langat
    Journal: Scientific African

  • Title: Forecasting Temperature Time Series Data Using Combined Statistical and Deep Learning Methods: A Case Study of Nairobi County Daily Temperature
    Authors: John Kamwele Mutinda, Amos Kipkorir Langat, Samuel Musili Mwalili, Ayesha Ikram
    Journal: International Journal of Mathematics and Mathematical Sciences

  • Title: Fighting the Monkeypox in Rwanda, An overview of current state and future recommendations
    Authors: Amos Kipkorir Langat, M.A. Rusho, E. Byiringiro, G.Y. Scott, A. Alhassan, V.K. Cyubahiro, C. Tague, E. Kihanduka, M. Nkeshimana, A. Akilimali
    Journal: New Microbes and New Infections

  • Title: Mixed Effects and Semi-Parametric Bayesian Integration Models for Measurement Error Correction in the Context of Fertilizer Application Levels: A Simulation Study
    Authors: Amos Kipkorir Langat, Samuel Musili Mwalili, Lawrence Ndekeleni Kazembe
    Journal: Communications in Mathematical Biology and Neuroscience

  • Title: Modeling the Impact of Air Pollution and Meteorological Variables on COVID-19 Transmission in Western Cape, South Africa
    Authors: John Kamwele Mutinda, Amos Kipkorir Langat
    Journal: International Journal of Mathematics and Mathematical Sciences

  • Title: Hierarchical Bayesian Semi-Parametric Models for Measurement Error Correction in Determining Optimal Fertilizer Application Levels
    Authors: Amos Kipkorir Langat, Samuel Musili Mwalili, Lawrence Ndekeleni Kazembe
    Journal: Scientific African

  • Title: Stock Price Prediction Using Combined GARCH-AI Models
    Authors: John Kamwele Mutinda, Amos Kipkorir Langat
    Journal: Scientific African

CONCLUSION

Dr. Amos Kipkorir Langat embodies a lifelong commitment to Global Health. His multidisciplinary approach integrates mathematics, statistics, and public policy to confront Global Health issues with clarity and innovation. From mentoring graduate students to shaping international research forums, his mission remains enhancing Global Health equity and resilience. He continuously leverages research, education, and collaboration to support sustainable Global Health systems. By embedding rigorous statistical analysis into every phase of his work, Dr. Langat ensures that Global Health challenges are met with scientifically grounded solutions. His legacy will persist through impactful research, strategic partnerships, and his unrelenting pursuit of excellence in Global Health scholarship.

Dr. Dimosthenis Chochlakis | Epidemiology of Emerging | Best Researcher Award

Published on by Infectious

Dr. Dimosthenis Chochlakis | Epidemiology of Emerging | Best Researcher Award

Dr. Dimosthenis Chochlakis | Epidemiology of Emerging - School of Medicine/University of Crete,Greece

Dimosthenis Chochlakis is a leading expert in the Epidemiology of Emerging pathogens, extensively contributing to public health through surveillance, diagnostics, and applied microbiology. His work spans over two decades, involving advanced research in molecular microbiology, public health, and zoonoses. With profound experience in the Epidemiology of Emerging infections, especially vector-borne and zoonotic diseases, he has shaped both national and international policies. He has delivered outstanding contributions to the Epidemiology of Emerging outbreaks and public health readiness, always highlighting the Epidemiology of Emerging risks related to environmental and vector-related sources. Through publications and collaborative research, he has advanced the scientific understanding of the Epidemiology of Emerging diseases. Dr. Chochlakis consistently integrates surveillance systems into real-time diagnostics focusing on the Epidemiology of Emerging bacteria and pathogens. His leadership roles have made him a key figure in promoting strategic frameworks for the Epidemiology of Emerging threats. The consistent drive for addressing global challenges related to the Epidemiology of Emerging pathogens underscores his academic and scientific influence. Dr. Chochlakis continues to promote interdisciplinary solutions in the Epidemiology of Emerging diseases domain through research, education, and translational diagnostics of the Epidemiology of Emerging microorganisms.

AUTHOR PROFILE 

ORCID | SCOPUS

EDUCATION

Dimosthenis Chochlakis’s educational foundation is firmly rooted in the Epidemiology of Emerging pathogens. He earned a PhD in Molecular Microbiology from the University of Crete with research focused on the Epidemiology of Emerging vector-borne diseases. His earlier education includes a BSc and MSc from the University of Surrey, where he explored the Epidemiology of Emerging infections using biochemical and molecular tools. Throughout his studies, his academic path remained tightly linked with the Epidemiology of Emerging pathogens and their impact on public and veterinary health. His doctoral research contributed to key discoveries in the Epidemiology of Emerging zoonoses, especially in the Mediterranean region. Dr. Chochlakis combined theoretical knowledge with applied science, always anchored in the Epidemiology of Emerging disease surveillance. His continuous learning through seminars and certifications on diagnostic methods in Epidemiology of Emerging infections fortified his capabilities. This education positioned him as a leader in understanding and combating the Epidemiology of Emerging microbial threats, while promoting innovation in academic and public health strategies concerning the Epidemiology of Emerging diseases landscape.

PROFESSIONAL EXPERIENCE

Dr. Chochlakis has amassed exceptional professional experience centered around the Epidemiology of Emerging pathogens. From his long-standing role at the Laboratory of Clinical Bacteriology, Parasitology, Zoonoses, and Geographical Medicine at the University of Crete to national collaborations, he has tackled challenges in the Epidemiology of Emerging infectious diseases. His work in microbiology and public health laboratories has shaped Greece’s response to the Epidemiology of Emerging zoonotic outbreaks. Across teaching roles and diagnostic research programs, his emphasis on the Epidemiology of Emerging bacteria remained unwavering. He was pivotal in implementing surveillance systems and outbreak response frameworks based on the Epidemiology of Emerging risk factors. His diagnostic acumen and managerial roles have continuously reinforced the Epidemiology of Emerging research agenda. Collaborating with multiple stakeholders, Dr. Chochlakis ensures that the Epidemiology of Emerging threats are monitored and mitigated effectively. His clinical and academic activities blend seamlessly to serve the evolving needs of the Epidemiology of Emerging risk landscape.

RESEARCH INTEREST

The Epidemiology of Emerging diseases is at the core of Dr. Chochlakis's research. He specializes in studying the Epidemiology of Emerging zoonotic pathogens, vector-borne bacteria, and antimicrobial resistance. His research spans molecular epidemiology, surveillance methodologies, and environmental microbiology, all focused on the Epidemiology of Emerging challenges. Projects under his guidance have investigated Legionella, Anaplasma, Q fever, and Rickettsia with an emphasis on understanding the Epidemiology of Emerging pathogens’ behavior across ecosystems. He leads investigations exploring pathogen interactions, vector dynamics, and diagnostic innovations contributing to the Epidemiology of Emerging insights. He also applies genomics and proteomics to decode the Epidemiology of Emerging infectious agents. His academic drive continually aims to identify control points within the Epidemiology of Emerging pathogen spread. His research outputs help refine early-warning systems and surveillance models for Epidemiology of Emerging threats in Europe and beyond. Through cross-disciplinary collaborations, Dr. Chochlakis advances the global knowledge base on the Epidemiology of Emerging infections and their societal impact.

AWARD AND HONOR

Dr. Dimosthenis Chochlakis’s contributions to the Epidemiology of Emerging pathogens have earned him significant recognition. He has been a guest editor for scientific journals on the Epidemiology of Emerging topics and has received national and European acknowledgments for his leadership in infectious disease surveillance. His selection as a COST Action member reinforces his expertise in the Epidemiology of Emerging threats. He has also served on major committees evaluating research funding applications focused on the Epidemiology of Emerging diseases. These honors affirm his scientific impact and leadership within the Epidemiology of Emerging academic community. His invited lectures, editorial roles, and reviewer appointments are all testimony to his authority in the Epidemiology of Emerging domain. Furthermore, his role in conference organization and curriculum development for infectious disease courses strengthens his standing as a global expert in the Epidemiology of Emerging pathogens. These distinctions reflect his pioneering vision and ongoing contributions to the Epidemiology of Emerging threats.

RESEARCH SKILL

Dr. Chochlakis’s research skills are deeply anchored in the Epidemiology of Emerging microbiological challenges. He masters techniques such as molecular diagnostics, GIS mapping, MALDI-TOF MS, and proteomic identification to study the Epidemiology of Emerging organisms. He excels in laboratory diagnostics and field epidemiology concerning the Epidemiology of Emerging outbreaks. He uses advanced sequencing technologies and data interpretation software to investigate the Epidemiology of Emerging infections at both environmental and clinical interfaces. His training in microbial isolation, pathogen surveillance, and biostatistical evaluation equips him to address the complexity of the Epidemiology of Emerging disease scenarios. Dr. Chochlakis mentors students and researchers in laboratory best practices related to the Epidemiology of Emerging disease surveillance. He ensures that research quality is maintained across every phase of the Epidemiology of Emerging data pipeline. His multidisciplinary skills allow the transformation of research data into actionable public health insights focused on the Epidemiology of Emerging risks.

PUBLICATIONS

Dr. Chochlakis has an extensive publication record highlighting the Epidemiology of Emerging bacterial infections. His over 70 peer-reviewed journal articles and book chapters span topics like Legionella, Anaplasma, Rickettsiae, and Q fever—all central to the Epidemiology of Emerging diseases. His publications address molecular surveillance, resistance trends, diagnostic innovations, and environmental monitoring related to the Epidemiology of Emerging pathogens. With frequent appearances in high-impact journals, his work contributes to defining standards in Epidemiology of Emerging research. Many of his papers serve as reference studies in the global understanding of the Epidemiology of Emerging infections. He has co-authored with prominent scientists worldwide to expand the reach of Epidemiology of Emerging analyses. His citation metrics and h-index reflect the scientific community’s recognition of his authoritative voice in Epidemiology of Emerging issues. Through data-driven analysis and empirical insights, Dr. Chochlakis has created a rich body of literature that will continue to influence Epidemiology of Emerging disease preparedness.

  •  Title: Comparative Risk Assessment of Legionella spp. Colonization in Water Distribution Systems Across Hotels, Passenger Ships, and Healthcare Facilities During the COVID-19 Era
    Authors: Antonios Papadakis; Eleftherios Koufakis; Elias Ath Chaidoutis; Dimosthenis Chochlakis; Anna Psaroulaki
    Journal: Water

 

  • Title: Recreational Water Safety in Hotels: Lessons from the COVID-19 Pandemic and the Way Forward for a Safe Aquatic Environment
    Authors: Antonios Papadakis; Dimosthenis Chochlakis; Eleftherios Koufakis; Vilelmine Carayanni; Anna Psaroulaki
    Journal: Tourism and Hospitality

 

  • Title: A Customizable Multiplex Protein Microarray for Antibody Testing and Its Application for Tick-Borne and Other Infectious Diseases
    Authors: Krishnamurthy H.; Jayaraman V.; Krishna K.; Wang T.; Bei K.; Suresh C.; Matilda S.; Rai A.; Welc-Falęciak R.; Pawełczyk A.; et al.
    Journal: Research Square

 

  • Title: Multi-Criterion Analysis of the Effect of Physico-Chemical Microbiological Agents on Legionella Detection in Hotel Water Distribution Systems in Crete
    Authors: Dimosthenis Chochlakis; Vassilis Sandalakis; Alexandros Ntoukakis; Maria-Olga Daskalaki; Thibaud Loppinet; Niki Thalassinaki; Rafaela Makridaki; Christos Panoulis; Anna Psaroulaki
    Journal: Frontiers in Cellular and Infection Microbiology

 

  • Title: Electrochemical Antigenic Sensor for the Diagnosis of Chronic Q Fever
    Authors: Eleni Mathioudaki; Yannis Alifragis; Maria Fouskaki; Dimosthenis Chochlakis; Haimin Xie; Anna Psaroulaki; Georgios Tsiotis; Nicholas Chaniotakis
    Journal: Current Research in Biotechnology

 

  •  Title: Giant Cell Arteritis Associated with Acute Q Fever – A Case Report
    Authors: Evangelia Sarra; Christos C. Mylonas; Georgios Tsekes; Dimosthenis Chochlakis; Anna Psaroulaki; Maria Chini
    Journal: Journal of Infection and Chemotherapy

CONCLUSION

Dr. Dimosthenis Chochlakis stands at the forefront of the Epidemiology of Emerging infectious diseases research. His legacy reflects decades of impactful contributions in pathogen surveillance, academic mentorship, and scientific inquiry. He combines academic excellence with public health urgency to respond to the Epidemiology of Emerging microbial threats. As new challenges evolve, his work remains essential for predictive modeling, diagnostic enhancement, and the control of Epidemiology of Emerging zoonotic and environmental diseases. He serves as an invaluable bridge between laboratory science and field epidemiology in addressing the Epidemiology of Emerging risks. His passion for microbiology, teaching, and innovation keeps him deeply engaged in improving responses to the Epidemiology of Emerging crises. Dr. Chochlakis continues to inspire global scientific communities through his leadership in the Epidemiology of Emerging pathogens domain and his strategic vision for public health resilience. His continued research will undoubtedly enhance the preparedness and response to the Epidemiology of Emerging threats worldwide.

Dr. Elham Kazemirad | Treatment for Infectious Diseases | Excellence in Research

Published on by Infectious

Dr. Elham Kazemirad | Treatment for Infectious Diseases | Excellence in Research

Dr. Elham Kazemirad | Treatment for Infectious Diseases - Department of Medical parasitology & Mycology, Tehran University of Medical Sciences , Iran

Dr. Elham Kazemirad is a renowned Associate Professor at the Department of Medical Parasitology and Mycology, Tehran University of Medical Sciences. Her research bridges clinical and molecular diagnostics, with a central focus on Treatment for Infectious Diseases. Over the years, her contributions have emphasized Treatment for Infectious Diseases across leishmaniasis, Acanthamoeba keratitis, and protozoan infections. Her work consistently explores innovative diagnostic and therapeutic strategies, reinforcing global capabilities in Treatment for Infectious Diseases. With a dynamic presence in academia, she has dedicated her career to advancing Treatment for Infectious Diseases through cutting-edge molecular biology, gene expression studies, and nanoparticle drug delivery. Dr. Kazemirad’s leadership and research continue shaping new pathways for Treatment for Infectious Diseases in both clinical and research settings.

AUTHOR PROFILE

ORCID | GOOGLE SCHOLAR

EDUCATION

Dr. Kazemirad holds a Ph.D., M.Sc., B.Sc., and Associate Degree in Medical Parasitology and Laboratory Sciences, all from top Iranian medical universities. Her Ph.D. thesis pioneered gene profiling in Leishmania tropica and explored mechanisms of drug resistance, directly contributing to Treatment for Infectious Diseases. Throughout her academic path, Treatment for Infectious Diseases remained a core theme, evident in her early thesis on PCR diagnostics and parasite detection. Her educational foundation was rigorously rooted in scientific innovation and clinical relevance, always aimed at improving Treatment for Infectious Diseases. This background has propelled her to become a thought leader whose educational milestones support groundbreaking discoveries in the Treatment for Infectious Diseases field.

PROFESSIONAL EXPERIENCE

Dr. Kazemirad has served as an Assistant and Associate Professor, and lab supervisor, contributing significantly to Treatment for Infectious Diseases since 2014. Her clinical laboratory leadership includes molecular diagnosis of parasitic diseases, microbial keratitis, and more, always reinforcing effective Treatment for Infectious Diseases. She combines teaching, clinical, and administrative roles to shape future parasitologists and advance diagnostics. At both Tehran University of Medical Sciences and Pasteur Institute of Iran, her dedication has been a cornerstone in Treatment for Infectious Diseases. She mentors students and leads research initiatives that redefine how Treatment for Infectious Diseases is applied and understood across academic, diagnostic, and healthcare platforms.

RESEARCH INTEREST

Dr. Kazemirad’s primary research interests center on drug resistance mechanisms, molecular diagnostics, and nanomedicine—all critical for effective Treatment for Infectious Diseases. Her passion for Treatment for Infectious Diseases drives projects involving gene expression in pathogens and the development of novel therapeutics. With expertise in biotechnology, immunology, and phylogenetics, she investigates the molecular basis of resistance and innovative drug delivery systems. Treatment for Infectious Diseases is not only her research focus but her mission. By integrating bioinformatics, molecular assays, and nanoparticle therapeutics, her research contributes vital knowledge and practical tools to improve Treatment for Infectious Diseases, especially among vulnerable and immunocompromised populations.

AWARD AND HONOR

Dr. Kazemirad has been consistently recognized for her academic excellence and innovation in Treatment for Infectious Diseases. She was ranked first in multiple academic programs and received distinctions for her graduate work in drug-resistant Leishmania. Her work in Treatment for Infectious Diseases has been honored through leadership roles in scientific congresses and editorial positions in top journals. These honors reflect her relentless commitment to advancing Treatment for Infectious Diseases through translational research and public health applications. The prestigious recognition from both Iranian and international institutions underscores her profound impact on Treatment for Infectious Diseases and her standing as a key contributor in parasitological and biomedical sciences.

RESEARCH SKILL

Dr. Kazemirad is proficient in molecular diagnostics, gene expression analysis, animal modeling, and nanoparticle-based therapeutics, all pivotal for enhancing Treatment for Infectious Diseases. Her skill set includes advanced techniques such as RT-PCR, Western blotting, cloning, proteomics, ELISA, gene silencing, and next-generation sequencing. Each technique is applied to understand, monitor, and improve Treatment for Infectious Diseases. Her expertise extends to developing diagnostic platforms for Acanthamoeba and Leishmania, along with testing novel compounds and nanoparticles. Treatment for Infectious Diseases is the core of her methodological approach, combining lab innovation with clinical relevance to transform how these diseases are managed and treated across diverse populations.

PUBLICATIONS

Dr. Kazemirad has authored over 50 peer-reviewed papers, all thematically aligned with Treatment for Infectious Diseases. Her publications focus on antimony resistance, nanoparticle therapies, gene expression in pathogens, and diagnostics for parasitic diseases. Each study enhances global strategies for Treatment for Infectious Diseases, often addressing neglected tropical diseases. Her work appears in top journals such as PLOS ONE, BMC Infectious Diseases, Acta Tropica, and the Iranian Journal of Parasitology. Her contributions serve as foundational references for researchers developing new modalities in Treatment for Infectious Diseases, bridging fundamental biology and translational medicine. The consistency and depth of her publications emphasize her leadership in Treatment for Infectious Diseases.

  • Title: Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice
    Authors: Saberi, M.; Latifi, A.; Golkar, M.; Fard-Esfahani, P.; Mohtasebi, S.; Teimouri, A.; Afshar, M.J.A.; Kazemirad, E.; Mohebali, M.
    Journal: PLoS Neglected Tropical Diseases

  • Title: High Prevalence of Enterocytozoon bieneusi Genotype BEB6 in Wild Boars in Lorestan Province, Iran: Potential Source of Zoonotic Transmission
    Authors: Javanmard, E.; Mohammad Rahimi, H.; Taghipour, A.; Nemati, S.; Mohebali, M.; Rezaeian, M.; Badrifar, A.; Kazemirad, E.; Mirjalali, H.
    Journal: Iranian Journal of Parasitology

  • Title: Molecular Identification of Nematodes (Superfamily: Strongylida) Traced in Herbivores Excrement in the Wildlife from Western Iran
    Authors: Vafaei, M.R.; Safaie, M.; Kazemirad, E.; Mirjalali, H.; Askari, Z.; Mohebali, M.; Mowlavi, G.
    Journal: SSRN

  • Title: Prevalence of free-living amoebae in five rivers associated with high human activity in Tehran province, Iran
    Authors: Javanmard, E.; Kazemirad, E.; Rahimi, H.M.; Mohebali, M.; Rezaeian, M.; Alimohammadi, M.; Mirjalali, H.
    Journal: Journal of Water and Health

  • Title: Transcriptional alterations of virulence factors in Leishmania major clinical isolates harboring Leishmania RNA virus 2 (LRV2)
    Authors: Sabeti, S.; Koosha, M.; Kazemirad, E.; Mirabedini, Z.; Mohebali, M.; Saberi, R.; Fakhar, M.; Hajjaran, H.
    Journal: BMC Infectious Diseases

CONCLUSION

Dr. Elham Kazemirad’s career epitomizes dedication to the Treatment for Infectious Diseases. Through her education, research, and professional engagements, she has elevated global understanding of parasitic diseases and their therapies. Her work integrates basic science and clinical innovation to offer novel solutions for Treatment for Infectious Diseases. From academic contributions to pioneering diagnostics and therapies, her impact is profound and ongoing. She remains a key influencer in shaping policies, mentoring future scientists, and leading research that targets resistant pathogens. As Treatment for Infectious Diseases continues to challenge global health, her expertise remains vital in guiding next-generation therapeutic advancements and public health solutions

Dr. Birsen Bulut Solak | Global Health | Best Researcher Award

Published on by Infectious

Dr. Birsen Bulut Solak | Global Health | Best Researcher Award 

Dr. Birsen Bulut Solak | Global Health – Selcuk University, Turkey

AUTHOR PROFILE

GOOGLE SCHOLAR

INTRODUCTION TO GLOBAL HEALTH CONTRIBUTIONS

Birsen Bulut-Solak is a distinguished Turkish scholar whose academic and professional journey is firmly anchored in advancing Global Health through the lens of food safety, nutrition, and dairy technology. With a career spanning over two decades, she has significantly impacted how food systems are understood and integrated into public health paradigms. Her work highlights the interplay between culinary traditions and scientific advancements, directly addressing the challenges of foodborne illnesses and malnutrition, two critical facets of Global Health. At Selcuk University, she currently serves as an Associate Professor in the Department of Gastronomy and Culinary Arts, where she continues to guide research, mentor students, and develop innovative curricula that reflect the growing demand for health-conscious culinary science. Her research focus on Food Safety at Catering, Traditional Foods, and Dairy Technology provides invaluable contributions to Global Health by ensuring the development of safe, nutritious, and culturally appropriate foods. Through her international collaborations, especially during her Post-Doctoral Fellowship in Ireland, she has cultivated a truly global perspective. Dr. Bulut-Solak’s interdisciplinary work merges technology, tradition, and health, proving instrumental in promoting sustainable food systems that support global nutrition goals and the health of populations worldwide.

EARLY ACADEMIC PURSUITS AND GLOBAL HEALTH ROOTS

Birsen Bulut-Solak’s journey into the field of Global Health began with her foundational education in Dairy Science and Technology at Ankara University. Her undergraduate and graduate studies laid a critical groundwork in understanding food composition, safety, and microbial properties, topics that are pivotal to public health. As a master’s student, she examined the chemical and microbial evolution of Mihalic cheese, highlighting the implications of raw and pasteurized milk—an issue closely tied to foodborne disease prevention in Global Health. Her PhD research further advanced this exploration, focusing on processing parameters and their effects on cheese quality, helping bridge the gap between traditional production and safe, scalable practices. These early academic endeavors show her growing dedication to integrating food engineering principles into improving health outcomes. Her academic maturity culminated during her postdoctoral studies in Ireland, where she worked on modifying milk protein functionality—a direct application in developing fortified foods for Global Health improvement. Her rigorous training and early scientific inquiry created a firm foundation for her lifelong mission: improving food systems for better public health, enhancing nutrition, and ensuring the safety of food consumed globally. Each academic phase of her life steadily expanded her scope and influence in Global Health discourse.

PROFESSIONAL ENDEAVORS ADVANCING GLOBAL HEALTH

Birsen Bulut-Solak’s professional trajectory reveals a persistent commitment to strengthening Global Health through education, research, and institutional leadership. Starting her career at Karapinar Aydoganlar Vocational College, she served not only as a lecturer but also as Head of Department and College Co-director. Her initiatives helped modernize the Food Processing and Dairy Technology programs, ultimately enhancing food safety practices at the grassroots level. Transitioning to Selcuk University’s Tourism Faculty, she led the Department of Gastronomy and Culinary Arts and later assumed roles as Assistant and then Associate Professor. In these roles, she has embedded Global Health principles across course offerings—from Nutrition and Food Microbiology to Food Safety at Catering. Her international research collaborations, most notably her postdoctoral tenure in Ireland, have expanded her academic network and research impact. As a referee for various food science journals and an Ambassador for the Global Harmonization Initiative, she champions standardized food safety practices across borders. Her multifaceted professional engagements—from organizing international food safety congresses to guiding BAP-funded research projects—reinforce her mission to elevate food safety and nutrition standards globally. Each role has been a strategic platform for advancing Global Health and promoting safer, healthier food systems worldwide.

CONTRIBUTIONS AND RESEARCH FOCUS IN GLOBAL HEALTH

Birsen Bulut-Solak’s research portfolio is rich with interdisciplinary studies that reinforce her contributions to Global Health. Her key interests—Food Safety at Catering, Traditional Foods, Nutrition, and Dairy Technology—intersect to address public health nutrition, particularly in vulnerable communities. By investigating the rheological and microstructural properties of dairy proteins, and promoting traditional fermented foods like kefir and tarhana, she underscores the health benefits of culturally significant diets in preventing disease and improving digestive health. Her work on Orchis anatolica gum in milk systems contributes to the development of functional foods that meet nutritional needs globally. Publications like “Food Safety Knowledge Among Food Handlers” and her collaborative book chapters on “Food and Beverage Operations and Safety” serve as crucial educational tools in the field of Global Health. Through BAP-funded projects, she has developed innovative materials like brochures and comics to raise food safety awareness among food handlers, directly impacting community health. These interventions bridge academic research and societal needs. Her ability to integrate tradition with modern science in food technology represents a unique model of using gastronomy as a Global Health intervention, contributing substantially to reducing foodborne illnesses and promoting dietary wellness across diverse populations.

ACCOLADES AND RECOGNITION IN GLOBAL HEALTH INITIATIVES

Birsen Bulut-Solak’s excellence in Global Health–oriented research has earned her prestigious accolades both nationally and internationally. She was awarded multiple incentives by TÜBİTAK and Selcuk University’s BAP for her high-impact scientific publications, a testament to the relevance and rigor of her work. One of the most distinguished honors was her selection for TÜBİTAK’s International Post-Doctoral Fellowship Programme in Ireland—a program designed to cultivate global expertise in science. These honors reflect her ability to translate scientific inquiry into real-world health improvements. As a panelist on honey sensory analysis and a frequent speaker at food safety congresses, she actively contributes to building food safety knowledge at both grassroots and expert levels. Her recognition as an Ambassador for the Global Harmonization Initiative affirms her leadership in promoting standardized, safe, and equitable food systems. She is also a valued referee for numerous international journals, reinforcing her role as a gatekeeper for scientific quality in the domain of food science and Global Health. These honors not only highlight her individual excellence but also amplify her capacity to influence systemic change. Dr. Bulut-Solak’s decorated academic path reflects a career dedicated to Global Health impact through food innovation and safety.

IMPACT AND INFLUENCE ON GLOBAL HEALTH POLICY AND PRACTICE

The impact of Birsen Bulut-Solak’s work on Global Health is evident in both academic and policy circles. Her research has influenced food safety practices, especially within tourism-based culinary environments in Turkey and beyond. By investigating food handler behaviors, developing sensory analysis models, and integrating local culinary heritage with food science, she has provided insights that inform national food safety standards and educational curricula. Her contributions to sustainable gastronomy tourism and food waste management in all-inclusive hotels align closely with the United Nations’ Sustainable Development Goals related to health and sustainability. Through her publications, workshops, and course leadership at Selcuk University, she empowers students and practitioners to adopt a Global Health mindset in their culinary and food safety practices. Her international engagements—from Ireland to Macedonia and the USA—have allowed her to share best practices, foster cross-cultural knowledge transfer, and expand her influence. Her work supports policymakers by offering data-driven, culturally contextualized insights into food systems. Through both academia and advocacy, Dr. Bulut-Solak has become a prominent figure in shaping how food safety and nutrition intersect with public policy, reaffirming her enduring impact on Global Health promotion across communities and professional networks worldwide.

LEGACY AND FUTURE CONTRIBUTIONS TO GLOBAL HEALTH

Looking ahead, Birsen Bulut-Solak’s legacy in Global Health is rooted in her unwavering commitment to integrating food science with public health needs. Her academic rigor and societal focus ensure that her contributions will continue to influence how food systems are designed and improved. As new global challenges emerge—from pandemics to climate-induced food insecurity—her research trajectory positions her to lead innovative solutions in safe food production, traditional nutrition, and dairy science. With an extensive background in education, she is shaping a new generation of scholars and practitioners who prioritize health, safety, and sustainability in food systems. Her planned and ongoing projects continue to explore ways of reducing foodborne illness, advancing nutritional health, and promoting the global relevance of traditional Turkish foods. As a thought leader and mentor, she is dedicated to enhancing scientific dialogue and expanding Global Health discourse through interdisciplinary platforms. Whether influencing curriculum reforms, conducting field-based interventions, or contributing to international publications, her role remains pivotal. Dr. Bulut-Solak’s enduring legacy will be defined by her ability to blend science with culture, technology with tradition, and local knowledge with global solutions—all in service of promoting equitable and sustainable Global Health outcomes.

NOTABLE PUBLICATION

  • Title: Health Benefits of Whey Protein: A Review
    Authors: B. Bulut-Solak, N. Akin
    Journal: Journal of Food Science and Engineering

  • Title: Functionality of Whey Protein
    Authors: B. Bulut-Solak, N. Akin
    Journal: International Journal of Health and Nutrition

  • Title: Konya’da Mevlevi Mutfağı Yiyeceklerinin Gastronomi Turizminde Canlandırılması
    Authors: M. Ertaş, B. Bulut-Solak, C.Ç. Kılınç
    Journal: Gazi Üniversitesi Turizm Fakültesi Dergisi

  • Title: Impact of Cooking pH Values on the Textural and Chemical Properties for Processed Cheeses with/without the Use of Traditional Village Cheese During Storage
    Authors: B. Bulut-Solak, N. Akin
    Journal: Food Science of Animal Resources

  • Title: Composition, Morphology and Pasting Properties of Orchis anatolica Tuber Gum
    Authors: B. Bulut-Solak, L. Alonso-Miravalles, J.A. O’Mahony
    Journal: Food Hydrocolloids

Souhir Belloumi – Antibiotics – Best Researcher Award

Published on by Infectious

Souhir Belloumi - Antibiotics - Best Researcher Award

Faculty of Sciences of Tunis and Center of Biotechnology of Borj Cedria - Tunisia

AUTHOR PROFILE

SCOPUS

🌟 INTRODUCTION TO ANTIBIOTICS RESEARCH EXCELLENCE

Souhir Belloumi is a dedicated junior researcher in Biological Sciences with a robust foundation in medical biotechnology, food preservation, and molecular biology. Her academic and professional trajectory reveals an intense focus on bioactive compounds, environmental applications, and especially the antimicrobial properties of essential oils as natural Antibiotics. Souhir has persistently explored how plant-derived substances function as sustainable and potent alternatives to conventional Antibiotics, particularly within the poultry and food industries. Her passion for Antibiotics stems from her early research days, where she discovered a unique niche between traditional botanical medicine and modern biochemical sciences. This interdisciplinary approach is central to her work, allowing her to contribute meaningful insights into the efficacy and shelf-life improvement of natural preservatives. With numerous scientific publications addressing the antibacterial, antifungal, and antioxidant properties of plant extracts, Souhir continually emphasizes the public health impact of Antibiotics derived from nature. Her contributions extend beyond lab-based experiments—she has worked with international institutions and industrial partners, reinforcing the applicability of her research. Through strategic innovation in essential oil chemistry and Antibiotics formulation, Souhir Belloumi demonstrates leadership in developing biopreservatives that serve both environmental and human health agendas, pushing the boundaries of what Antibiotics research can achieve in the 21st century.

📚 EARLY ACADEMIC PURSUITS IN ANTIBIOTICS SCIENCE

Souhir Belloumi’s academic journey into the field of Antibiotics began with a Bachelor's in Medical Biotechnology focused on Molecular Engineering from the University of Tunis El-Manar. Her early exposure to molecular microbiology and diagnostic kit development at the Pasteur Institute in Tunisia gave her foundational knowledge in DNA/RNA extraction, PCR techniques, and vaccine research, which are essential pillars in Antibiotics discovery and delivery. During her dual Master’s programs in Environment Biomonitoring and Biological Sciences, she developed a keen interest in the intersection of environmental factors and microbial resistance, particularly as it applies to naturally occurring Antibiotics in plant systems. Her PhD research at the University of Tunis El-Manar further honed her focus on the biological effects of essential oils, where she pioneered analytical techniques using LC-MS/MS to characterize plant compounds for Antibiotics potential. Her academic success was marked by hands-on research that continually returned to the central theme of natural Antibiotics, culminating in advanced knowledge of their chemical composition, antibacterial mechanisms, and preservation roles. These formative experiences shaped Souhir’s vision of advancing global health through sustainable Antibiotics, fusing molecular biology with nature’s own antimicrobial arsenal. Her education laid the groundwork for innovative, translational Antibiotics research.

🧪 PROFESSIONAL ENDEAVORS IN ANTIBIOTICS INNOVATION

Souhir Belloumi’s professional trajectory demonstrates her deep commitment to advancing Antibiotics research, particularly through applied biotechnology and food science. As a research scientist at the Laboratory of Bioactive Substances at the Center of Biotechnology of Borj-Cedria, she led studies focused on isolating bioactive compounds and testing their Antibiotics capabilities, especially within the poultry industry. Her collaboration with Poulina Holdings enabled the transition of lab-based discoveries into scalable industrial applications, offering natural Antibiotics alternatives that align with consumer safety and environmental responsibility. During her tenure as a research intern at the University of Pisa’s Department of Pharmacy, she worked on cutting-edge compound identification using LC-MS/MS, contributing to the broader pharmacognosy field and enhancing understanding of plant-derived Antibiotics. Her international experience bolstered her analytical skills and exposed her to interdisciplinary perspectives on Antibiotics efficacy. In every professional role, whether in Tunisia or abroad, Souhir maintained a steadfast focus on developing efficient, eco-friendly Antibiotics solutions that tackle microbial resistance without contributing to chemical pollution. Her contributions also span virology, environmental microbiology, and food analysis—each reinforcing the central role of Antibiotics in human and animal health. Her work not only bridges disciplines but redefines the role of natural Antibiotics in global antimicrobial strategies.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ANTIBIOTICS

Souhir Belloumi’s research contributions focus predominantly on the development and evaluation of bioactive compounds as viable Antibiotics alternatives. She has co-authored multiple peer-reviewed articles analyzing the antimicrobial and antioxidant potentials of essential oils such as Schinus molle and Tetraclinis articulata, exploring their synergy and effectiveness against various foodborne pathogens. These studies demonstrated how plant-derived Antibiotics can extend shelf life, maintain food safety, and combat resistant strains. Her work has gone beyond identification, venturing into the mechanistic pathways of how these Antibiotics act on microbial cells. Souhir’s focus on fractionation, compound purification, and chemical profiling via GC-MS and LC-MS/MS tools has made her a leading figure in natural Antibiotics analysis. Furthermore, her interdisciplinary methodology integrates food chemistry, microbiology, and immunology, emphasizing how natural preservatives can act as potent Antibiotics. By blending sensory evaluation with microbial inhibition assays, she provides a comprehensive approach to natural preservative development. Her research significantly contributes to the growing discourse on antimicrobial resistance, offering a nature-based solution. Through her dedication to Antibiotics innovation, she has helped establish evidence-based practices for utilizing essential oils in both medical and food-related applications, ensuring a sustainable and health-conscious future grounded in natural Antibiotics research.

🏅 ACCOLADES AND RECOGNITION IN ANTIBIOTICS SCIENCE

Souhir Belloumi’s work in Antibiotics research has garnered increasing recognition, particularly in international scientific circles focused on food safety and natural therapeutics. Her publication in Food Chemistry on essential oils as chicken meat preservatives is widely cited, highlighting her critical role in the advancement of natural Antibiotics applications. Her collaborative efforts with national and international laboratories have been praised for their methodological rigor and relevance in the context of antimicrobial resistance. Souhir has completed multiple prestigious certifications, including Statistical Analysis and QSE System Management, further solidifying her technical and regulatory expertise within the Antibiotics field. Her participation in the GIZ Master-Class in Germany demonstrates her leadership potential in managing interdisciplinary research on water and health sciences, closely related to microbial control via Antibiotics. These experiences have strengthened her capacity to act as a global voice in antimicrobial innovation. She is often acknowledged for integrating statistical modeling with chemical and microbiological evaluation to validate the efficacy of new Antibiotics solutions. In every professional development endeavor, the common thread is her emphasis on effective, safe, and environmentally sustainable Antibiotics technologies. Her awards and recognitions underscore her role as an emerging leader in natural Antibiotics discovery and deployment for both public health and industrial needs.

🌍 IMPACT AND INFLUENCE THROUGH ANTIBIOTICS RESEARCH

Souhir Belloumi’s influence extends across the domains of microbiology, biotechnology, and environmental health, all rooted in the powerful application of Antibiotics derived from natural sources. Her interdisciplinary research has impacted food preservation practices by introducing natural Antibiotics as effective alternatives to synthetic chemical preservatives. This has vast implications for reducing antimicrobial resistance globally. By collaborating with academic institutions, industrial sectors, and research labs in Tunisia and Europe, Souhir has fostered knowledge exchange that drives innovation in natural Antibiotics. Her mentoring of peers and sharing of experimental design insights has inspired a new generation of scientists to pursue research focused on sustainable Antibiotics. The broader health community benefits from her findings, especially in regions vulnerable to foodborne illness and limited pharmaceutical access. Her advocacy for integrating essential oils into public health frameworks contributes to national discussions on safe Antibiotics use in agriculture and food production. In scholarly forums and industry settings, Souhir promotes the role of bio-based Antibiotics in achieving both food security and antimicrobial stewardship. Her contributions continue to shape policy, inspire innovation, and enhance global understanding of natural Antibiotics as not just alternatives—but as necessities—in the fight against microbial threats.

🧬 LEGACY AND FUTURE CONTRIBUTIONS IN ANTIBIOTICS SCIENCE

Looking ahead, Souhir Belloumi envisions a future where Antibiotics derived from natural sources are central to global antimicrobial policy, sustainable agriculture, and health innovation. Her legacy is already taking form through her influential publications, global collaborations, and a clear focus on integrating essential oils and botanical extracts into mainstream Antibiotics strategies. With antimicrobial resistance posing a growing global threat, she plans to extend her research to cover synergistic formulations that enhance the potency of plant-based Antibiotics while minimizing cytotoxicity and side effects. Her next frontier includes exploring nanotechnology for enhanced delivery of Antibiotics compounds, potentially revolutionizing how infections are managed in both humans and animals. She is committed to educating future scientists, advocating for environmentally conscious Antibiotics development, and influencing health policies that embrace nature-based solutions. Through continuous innovation, publication, and public engagement, Souhir aims to establish international research platforms that prioritize natural Antibiotics over synthetic alternatives. Her enduring goal is to ensure that global communities, especially in the Global South, have access to affordable, effective, and sustainable Antibiotics. This vision cements her status as a pioneer in shaping a future where Antibiotics are no longer pollutants but protectors—rooted in nature, validated by science, and embraced by society.

NOTABLE PUBLICATION

  • Title: Combined essential oils as natural chicken meat preservatives: chemical composition, biological activities, synergy and shelf-life extension potential
    Authors: (Not fully listed in your message – please provide full author list or upload the article if you have it)
    Journal: Food Chemistry
    Year: 2025

Marwa Abozed – Antibiotic – Best Researcher Award

Published on by Infectious

Marwa Abozed - Antibiotic - Best Researcher Award

Zagazig University Faculty of Human Medicine - Egypt

AUTHOR PROFILE

ORCID

🌟 INTRODUCTION TO ACADEMIC EXCELLENCE

Dr. Marwa Fady Mohamed Abd El Hamed stands as a dedicated scholar and innovator in the field of microbiology with an enduring focus on Antibiotic resistance and biofilm-related infections. Her academic journey, rooted in the Faculty of Pharmacy, Zagazig University, led to a PhD and a trajectory of significant contributions in teaching, research, and global academic collaboration. As an Assistant Professor at the Modern University for Technology and Information, Dr. Marwa merges education with frontline research, particularly on Antibiotic resistance, natural antibiofilm agents, and microbial pathogenesis. Her tenure across academic institutions in Egypt and Saudi Arabia—Delta University, Al-Ghad International Colleges, Buraidah Private Colleges—equipped her with a rich interdisciplinary teaching portfolio. She enhanced her global insight as a visiting scholar at the University of Dayton, Ohio, expanding her expertise in microbiological innovation. Throughout her research and teaching career, Dr. Marwa has consistently prioritized infection control and the evolving threat of Antibiotic resistance. Her involvement in international conferences and editorial boards further reflects her prominence in the scientific community. Grounded in a vision for integrative and sustainable microbiological solutions, she remains committed to shaping the future of Antibiotic research and education through rigorous scientific pursuit and impactful knowledge dissemination.

📘 EARLY ACADEMIC PURSUITS

Dr. Marwa’s academic roots were firmly planted at Zagazig University, where she obtained her Bachelor's, Master's, and Ph.D. degrees from the Faculty of Pharmacy, with all degrees centered on microbiology and its intersection with Antibiotic studies. Her early academic interests were already aligned with understanding microbial infections and the pharmacological interventions necessary to counteract them. During her graduate years, she explored the dynamics of Antibiotic resistance and bacterial biofilms—two of the most pressing challenges in medical microbiology. Her master’s thesis delved into microbial behavior under pharmacological stress, while her doctoral work addressed innovative strategies to detect and neutralize biofilm-associated pathogens. This formative academic period laid the foundation for her later focus on natural antibiofilm agents and their synergy with conventional Antibiotic treatments. Her training included intensive workshops in presentation skills, communication, and quality control—all contributing to her role as an educator and researcher. With early exposure to advanced clinical laboratory techniques and strategic thinking in drug design and microbial diagnostics, Dr. Marwa became exceptionally skilled in bridging theoretical science with practical Antibiotic applications. This early phase fostered a lifelong passion for tackling microbial resistance, promoting Antibiotic stewardship, and mentoring the next generation of microbiologists dedicated to combating superbugs and infection control.

🧪 PROFESSIONAL ENDEAVORS IN MICROBIOLOGY

Dr. Marwa Fady has pursued an impressive professional trajectory, dedicating her expertise to both academic and clinical institutions. Her work spans roles as a lecturer, microbiologist, and quality coordinator at prestigious institutions including Delta University, Al-Ghad International Colleges, and Buraidah Private Colleges in Saudi Arabia. Throughout these roles, she consistently infused her curriculum with cutting-edge knowledge on Antibiotic resistance mechanisms, biofilm formation, and infection control. As a team leader for self-study and quality assurance at Al-Ghad, she integrated Antibiotic stewardship modules into program evaluations. Additionally, her responsibility for graduation projects in clinical laboratories allowed her to mentor students on the development of innovative Antibiotic testing methods and natural antimicrobial compound screenings. At Zagazig University Hospital, she contributed to infection control programs and joined quality teams addressing Antibiotic medication management. Her multidisciplinary teaching spans General Microbiology, Immunology, Clinical Bacteriology, and Public Health, where the theme of Antibiotic relevance remains ever-present. Each position Dr. Marwa held amplified her influence over how Antibiotic resistance is studied, taught, and applied. Her passion for practical impact, paired with research leadership, continues to empower students and peers to adopt more sustainable and effective Antibiotic applications across pharmacy and health sciences education.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Marwa Fady’s research portfolio is deeply rooted in exploring novel solutions to Antibiotic resistance and biofilm-associated infections. Her publications span internationally reputed journals and address themes like antibiofilm strategies, synergistic effects of natural compounds with Antibiotic agents, and microbial behavior modulation. Her 2025 publication on chitosan-based microneedles for antifungal delivery exemplifies translational research where drug delivery innovation meets microbiological efficacy. Other landmark studies include the use of graphene oxide-cranberry hydrogels in antibiofilm wound healing and pH-sensitive nanocarriers for antimicrobial therapy. Her pioneering research bridges nanotechnology and Antibiotic pharmacology, offering advanced drug delivery systems that enhance Antibiotic performance and reduce toxicity. Additionally, her in vivo and in silico analyses of natural products like Rumex vesicarius highlight her dedication to identifying sustainable antimicrobial alternatives. Her earlier works addressed bacterial behavior in NICUs and biofilm response to common clinical nutrients and Antibiotic combinations. Dr. Marwa’s scientific curiosity and methodical rigor continue to shape her vision: tackling microbial resistance through interdisciplinary research, natural agent discovery, and personalized Antibiotic therapy. She believes the future of Antibiotic science lies in precision, sustainability, and biocompatibility—principles she champions across every experiment, conference paper, and student thesis she mentors.

🏅 ACCOLADES AND RECOGNITION

Dr. Marwa Fady’s commitment to advancing Antibiotic science and microbiological education has earned her numerous accolades and distinguished appointments. She serves as an Editorial Board Member for Frontiers in Environmental Microbiology and is a reviewer for high-impact journals like Bentham, reflecting her global credibility in Antibiotic and biofilm research. Her speaking engagements at international conferences, such as the 7th International Conference on Drug Discovery and Therapy in UAE, have positioned her as a respected thought leader in natural Antibiotic innovations. At the First Scientific Conference of Microbiology at Zagazig University and subsequent symposia, she was honored for her engaging presentations and novel insights into Antibiotic synergy with phytochemicals. Her projects have often received institutional commendation for addressing real-world infection control challenges and for promoting novel biofilm inhibition techniques. Dr. Marwa’s teaching excellence, underscored by her student feedback and curriculum innovations in Antibiotic topics, has also been repeatedly recognized. Her role in designing self-evaluation frameworks and quality assurance models in education further highlight her leadership and system-thinking abilities. Every honor she receives reinforces her lifelong mission: to evolve Antibiotic science through rigorous inquiry, collaborative learning, and cross-disciplinary solutions.

🌍 IMPACT AND INFLUENCE

Dr. Marwa Fady’s influence transcends academia, impacting public health, clinical education, and pharmaceutical research. Her persistent focus on Antibiotic efficacy, resistance mechanisms, and biofilm mitigation has made her a leading voice in global microbiology networks. Through her teaching, she has mentored hundreds of students who now contribute to Antibiotic stewardship programs and infectious disease prevention across diverse health systems. Her published research is not only cited in academic texts but also used in practical settings where Antibiotic choices affect patient outcomes. Her collaborations with international researchers on multi-component delivery systems for Antibiotic drugs extend her impact beyond Egypt and Saudi Arabia to broader global healthcare systems. As a quality assurance expert, her frameworks for institutional improvement have empowered universities to embed Antibiotic safety and usage training across curricula. Moreover, her public health initiatives—particularly her infection control work at Zagazig University Hospital—continue to serve as best-practice models. Whether in a classroom, hospital ward, or scientific symposium, Dr. Marwa’s influence remains firmly tied to her vision of advancing Antibiotic science as a societal cornerstone. Her efforts resonate in every hospital protocol, student dissertation, and policy guideline that prioritizes responsible and effective Antibiotic application.

🧬 LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Dr. Marwa Fady is poised to leave a lasting legacy as a pioneer in Antibiotic resistance research and translational microbiology. Her career trajectory continues to evolve with an eye toward novel technologies, such as CRISPR-based bacterial gene editing and smart biomaterials for controlled Antibiotic release. She is actively developing interdisciplinary partnerships that integrate nanomedicine, artificial intelligence, and molecular diagnostics to personalize Antibiotic treatments. Her upcoming research aims to explore underutilized botanicals as sources for next-generation Antibiotic agents, thereby reducing the burden of synthetic drug overuse. Dr. Marwa also intends to establish an Antibiotic Research Innovation Center, where students and experts will jointly tackle the rise of multidrug-resistant pathogens. Her pedagogical reforms are designed to instill early awareness of Antibiotic stewardship in future pharmacists and clinical scientists. Through publications, mentorship, and cross-border collaborations, she is crafting a resilient scientific ecosystem where Antibiotic innovation thrives sustainably. Her future is not merely in research papers but in the clinical tools, protocols, and policies influenced by her insights. Dr. Marwa Fady’s legacy will remain embedded in every initiative that values responsible Antibiotic use, patient safety, and the relentless pursuit of microbial understanding for public health betterment.

NOTABLE PUBLICATION

  • Title: Chitosan-Based Intelligent Microneedles for Delivery of Amphotericin B Loaded Oleosomes: Antifungal Ocular Patch Targeting for Effective Against Fungal Keratitis Using Rabbit Model via TLR4/NLRP3 Pathway
    Author: Marwa Fady
    Journal: International Journal of Nanomedicine
    Publication Date: 2025-04-30

 

  • Title: Polylactic-Co-Glycolic Acid/Alginate/Neem Oil-Reduced Graphene Oxide as a pH-Sensitive Nanocarrier for Hesperidin Drug Delivery: Antimicrobial and Acute Otitis Media Assessments
    Authors: Saeed Al Zuhairy, Sammar Fathy Elhabal, Mohamed Fathi Mohamed Elrefai, Sandra Hababeh, Jakline Nelson, Marwa Fady, Nahla A. Elzohairy, Tassneim M. Ewedah, Ibrahim S. Mousa, Ahmed M. Hamdan
    Journal: Pharmaceuticals
    Publication Date: 2025-03-07

 

  • Title: Effect of β-sitosterol on PEL and PSL of Pseudomonas aeruginosa
    Authors: Marwa Fady, Y. Irie, R.M. Aljowaie, S. Musaed Almutairi
    Journal: Journal of King Saud University - Science
    Publication Year: 2024

 

  • Title: Enhancing Photothermal Therapy for Antibiofilm Wound Healing: Insights from Graphene Oxide-Cranberry Nanosheet Loaded Hydrogel in vitro, in silico, and in vivo Evaluation
    Authors: Sammar Elhabal, Saeed Al Zuhairy, Mohamed El-Nabarawi, Mohamed Elrefai, Mai Shoela, Sandra Hababeh, Jakline Nelson, Mohamed Abdel Khalek, Marwa Fady, Nahla Elzohairy, et al.
    Journal: International Journal of Nanomedicine
    Publication Date: 2024-12

 

  • Title: Evaluation of antibiofilm and cytotoxicity effect of Rumex vesicarius methanol extract
    Authors: Marwa Fady, H. Rizwana, K.M. Alarjani, M.A. Alghamdi, S.S. Ibrahim, J. Geyer, A. Abbas
    Journal: Open Chemistry
    Publication Year: 2023

 

  • Title: Efficacy of Ethanol Extract from Leaves Of Malva parviflora to Inhibit Bacterial Biofilm Formation
    Authors: Marwa Abozed, Nadia Hashish, Magda Gazer
    Journal: Journal of Molecular Biology Research
    Publication Date: 2018-04-19

ADELAIDA LAMAS FERREIRO – Antibiotic – Best Researcher Award

Published on by Infectious

ADELAIDA LAMAS FERREIRO - Antibiotic - Best Researcher Award

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL. UNIVERSIDAD DE ALCALÁ. MADRID - Spain

AUTHOR PROFILE

GOOGLE SCHOLAR

INTRODUCTION TO A LIFETIME OF CARE 🌍

Dr. Adelaida Lamas stands as a remarkable figure in pediatric pulmonology, with an illustrious career centered on cystic fibrosis and the vital role of antibiotic therapies. Her clinical dedication has spanned more than two decades, particularly in respiratory medicine, where her expertise has reshaped the management of chronic infections in pediatric patients. She has led national efforts to refine antibiotic administration strategies in cystic fibrosis, directly influencing treatment protocols and patient outcomes. As the principal investigator at the Ramón y Cajal Institute for Health Research (IRYCIS), she spearheaded pioneering research in pulmonary microbiology, emphasizing the interplay between antibiotics and microbial resistance. Her advocacy for inhaled antibiotic therapies was instrumental in expanding access to life-prolonging treatments. From neonatology to intensive care, Dr. Lamas’s practice was always anchored in evidence-based medicine and ethical care. Her guidance as an expert with the Spanish Agency for Medicines and Health Products (AEMPS) further established her as a key voice in antibiotic evaluation and therapeutic positioning. Dr. Lamas’s work not only provided clinical clarity but also raised the standard of care across Europe. Through antibiotic-driven protocols, she has improved survival and quality of life for countless children. Her legacy begins here, with antibiotics at its heart.

EARLY ACADEMIC PURSUITS 📚

Adelaida Lamas’s journey into pediatric pulmonology and antibiotic therapeutics began with rigorous medical education at the Universidad de Valladolid, followed by her specialization at the Ramón y Cajal University Hospital. Her early academic focus was deeply rooted in pediatric respiratory pathophysiology, especially how antibiotics influence outcomes in cystic fibrosis and critical care. During her doctoral studies at the Universidad Autónoma de Madrid, her award-winning thesis examined sedation monitoring in critically ill children—a project intersecting with the timing and dosing of antibiotics in intensive care. Her early exposure to pediatric infectious disease units shaped her understanding of antibiotic resistance, prompting her to explore novel modes of delivery like aerosolized antibiotics for neonatal care. She also participated in cross-institutional training in Spain and the United States, further deepening her comprehension of global antibiotic stewardship. These foundational years fostered her lifelong commitment to evidence-based antibiotic applications. Recognizing the intricacies of microbiome-antibiotic interactions, she published early papers that addressed microbial colonization in children and the antibiotic responses in respiratory infections. Her training laid a powerful groundwork, allowing her to rise not just as a clinician, but as an antibiotic-conscious academic. This early pursuit set the tone for decades of innovation centered on children’s health and antibiotic optimization.

PROFESSIONAL ENDEAVORS 🏥

Dr. Adelaida Lamas’s professional career spans over 25 years, during which she served as a consultant pediatric pulmonologist at the Ramón y Cajal University Hospital. There, she became the national reference point for cystic fibrosis management and antibiotic strategy development. One of her hallmark contributions was leading the design and oversight of antibiotic protocols within Spain’s CF newborn screening programs. Her expertise expanded into bioethics and clinical decision-making, where she lectured extensively on the appropriate use of antibiotics in pediatric populations. As a member of multiple national and international ethics and clinical trial committees, she advocated for safe and timely antibiotic use in vulnerable children. She also evaluated pediatric antibiotics for the Spanish Agency for Medicines and Health Products (AEMPS), helping shape regulatory decisions. Through her work with the European clinical trials initiative (Conect4children), she contributed to global guidelines for pediatric antibiotic trials. Her involvement in therapeutic positioning reports for inhaled antibiotics like tobramycin and aztreonam further positioned her as a thought leader in this field. Her daily practice married compassion with precision, always anchored in responsible antibiotic use. Dr. Lamas not only advanced care but reshaped antibiotic discourse in pediatrics through decades of resolute clinical endeavor and scholarly service.

CONTRIBUTIONS AND RESEARCH FOCUS 🔬

Throughout her prolific research career, Dr. Adelaida Lamas has published over 35 high-impact studies that focus on the intersection of pulmonary infections and antibiotic effectiveness in children with cystic fibrosis. Her groundbreaking work explored biofilm dynamics and how early antibiotic intervention alters pathogen colonization in respiratory tracts. She led key studies on the inhaled use of aztreonam, tobramycin, and other novel antibiotics that redefined how recurrent Pseudomonas aeruginosa infections are managed in chronic respiratory diseases. With collaborators from top European institutions, she investigated antibiotic heterogeneity and its role in resistance modulation. A strong advocate for combining antibiotics with probiotics, Dr. Lamas contributed to integrative therapeutic models that reduced microbial imbalance in CF patients. Her work in metaproteomics and gut microbiota establishment further emphasized the systemic effects of prolonged antibiotic use, positioning her as a forerunner in microbiome-aware therapy. Her leadership in randomized controlled trials ensured the ethical and scientific rigor of new antibiotic formulations. Her team’s publications are now widely cited in CF and pediatric pulmonology literature, influencing clinical guidelines across Europe. In short, her research has consistently pushed forward the boundaries of antibiotic science, ensuring that every child treated today benefits from decades of careful, research-driven innovation.

ACCOLADES AND RECOGNITION 🏅

Dr. Adelaida Lamas’s exceptional contributions to pediatric pulmonology and antibiotic therapies have garnered widespread recognition across clinical, academic, and governmental institutions. In 2006, her doctoral thesis received Spain’s “Dra. Juana Román First Prize,” the highest national honor in pediatric research. Her continued leadership earned her a permanent seat at the Spanish Agency for Medicines and Health Products (AEMPS), where she advised on pediatric antibiotic approvals. As principal investigator of several national and European antibiotic-related trials, she secured funding from global pharmaceutical leaders including Gilead and AstraZeneca. These trials revolutionized how antibiotic inhalation therapies are evaluated and prescribed for cystic fibrosis patients. Her recognition extended internationally when she was appointed as a key expert in pediatric pulmonology for Conect4children (c4c), shaping pan-European guidelines on antibiotic use in pediatric trials. Her teaching excellence earned her appointments at the Universidad de Alcalá and the International University of La Rioja, where she taught ethics in the use of antibiotics. Her voice is respected in editorial boards and therapeutic committees, particularly those focused on antibiotic innovation. In every honor received, the thread of her dedication to safe and effective antibiotic use in children remains central. Recognition of her work reflects the enduring impact of her antibiotic-focused legacy.

IMPACT AND INFLUENCE 🌐

The influence of Dr. Adelaida Lamas extends beyond the boundaries of her hospital and even her country. Her work in optimizing antibiotic protocols for pediatric pulmonology has inspired health policy reforms and research innovations globally. As one of the earliest adopters of inhaled antibiotic therapies, she helped bring these strategies from niche practices into standard protocols for cystic fibrosis patients. Her lectures on antibiotic resistance, ethical stewardship, and individualized therapy have been delivered across Europe and Latin America, where her voice commands respect and attention. Dr. Lamas’s influence is evident in international registries and multi-center trials, where her research and clinical models have been replicated. She has contributed significantly to the Spanish Federation of Cystic Fibrosis, promoting antibiotic literacy among patients and caregivers. Under her guidance, new pediatric pulmonologists have emerged, many of whom now lead CF units inspired by her antibiotic-focused methodologies. Her role in ethics committees ensured that antibiotic trials respect both safety and urgency—setting a benchmark for pediatric medicine. Dr. Lamas continues to shape antibiotic narratives through advisory boards, regulatory commissions, and academic forums. Her broad impact lies in proving that antibiotics, when used judiciously, are not just drugs—they are lifelines forged through science and compassion.

LEGACY AND FUTURE CONTRIBUTIONS 🌱

As Dr. Adelaida Lamas transitions from her active clinical roles, her legacy in pediatric pulmonology and antibiotic stewardship continues to flourish. She has trained countless professionals who now carry her antibiotic philosophy into new generations of care. Her published works serve as cornerstone references in antibiotic-based CF management and are embedded in Spain’s national respiratory care protocols. Beyond academia and hospitals, her advocacy has reached families and patients directly, helping demystify antibiotic use and resistance. Her future impact will unfold through her ongoing doctoral advisement roles, where she continues to guide research in hypertonic saline, probiotics, and next-generation antibiotics. She is also shaping ethical standards for emerging pediatric trials involving biologics and gene therapies, where the antibiotic baseline remains critical for infection control. With a strong foundation in both research and humanistic care, Dr. Lamas’s voice will remain central in regulatory debates and academic dialogues. Her legacy is proof that when science, ethics, and heart converge—especially around something as vital as antibiotics—the result is transformative. Looking ahead, she aims to contribute further by writing, mentoring, and consulting, all while ensuring that antibiotics remain a tool of precision, protection, and possibility for the children of tomorrow.

NOTABLE PUBLICATION

  • Title: Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey
    Authors: P. Mondejar-Lopez, E. Quintana-Gallego, R.M. Giron-Moreno, et al.
    Journal: Respiratory Medicine, Vol. 170, Article 106062, 2020

  • Title: Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis
    Authors: M.C. Megías, O.G. Albarrán, P.G. Vasco, A.L. Ferreiro, L.M. Carro
    Journal: Endocrinología y Nutrición (English Edition), Vol. 62(2), Pages 91–99, 2015

  • Title: A comprehensive evaluation of omega-3 fatty acid supplementation in cystic fibrosis patients using lipidomics
    Authors: Ó. Pastor, P. Guzmán-Lafuente, J. Serna, M. Muñoz-Hernández, A.L. Neyra, et al.
    Journal: The Journal of Nutritional Biochemistry, Vol. 63, Pages 197–205, 2019

  • Title: Protocol for the diagnosis and follow up of patients with cystic fibrosis
    Author: S. Gartner
    Journal: Anales de Pediatría (Barcelona, Spain: 2003), Vol. 71(3), Pages 250–264, 2009

  • Title: Tolerance of two inhaled hypertonic saline solutions in patients with cystic fibrosis
    Authors: L.M. Carro, A.L. Ferreiro, M.R. de Valbuena Maiz, C.W. Struwing, G.G. Álvarez, et al.
    Journal: Medicina Clínica, Vol. 138(2), Pages 57–59, 2012

Hoda Ameen – Plant pathology – Best Researcher Award

Published on by Infectious

Hoda Ameen - Plant pathology - Best Researcher Award

National Research Centre - Egypt

AUTHOR PROFILE

ORCID
GOOGLE SCHOLAR

🌱 A LEGACY ROOTED IN SCIENCE: INTRODUCTION

Prof. Hoda Hussein Amin Mohamed stands as a towering figure in the field of Plant Pathology, serving as Emeritus Research Professor at Egypt’s National Research Center. Her scientific journey, deeply embedded in agricultural nematology and biological control, reflects decades of unwavering dedication to sustainable agricultural development. From her formative education at Cairo University to leading national research missions, her academic and professional ascent has significantly shaped the discipline of Plant Pathology in Egypt and beyond. Early in her career, she focused on biological studies of nematodes, later earning her PhD with research on non-chemical resistance methods—an approach that would come to define her ecological ethos. Prof. Hoda's work bridges traditional expertise with innovative biotechnology, tackling complex nematode infestations through microbial interventions and plant defense elicitors. Her commitment to Plant Pathology is underscored not just by extensive scientific output, but also by her mentorship of future scientists, involvement in multidisciplinary projects, and active participation in international conferences. In an era where agricultural health is critical to food security, Prof. Hoda’s foundational contributions in Plant Pathology continue to offer enduring solutions. Her biography is a tribute to lifelong excellence and tireless pursuit of scientific truth in Plant Pathology.

🎓 EARLY ACADEMIC PURSUITS AND DISCIPLINED GROWTH

Prof. Hoda Hussein Amin Mohamed’s academic pathway reflects a deep-rooted passion for agricultural sciences, culminating in her life-long specialization in Plant Pathology. She began her journey with a Bachelor’s degree from Cairo University in Agricultural Sciences, focusing on pests and plant protection. Her pursuit of higher education led her to a Master’s in Agricultural Nematology, with a thesis examining the biology of Mononchida nematodes in Egypt—setting the foundation for her future focus in Plant Pathology. Her doctoral work tackled innovative, non-chemical resistance strategies against nematodes, highlighting her early commitment to sustainable pest control. These academic foundations were not only rigorous but visionary, aiming to tackle one of the most complex challenges in Plant Pathology—parasitic nematodes. During her academic progression, Prof. Hoda was inspired by ecological ethics and the need for biotechnological integration in soil health. Her scholarly focus earned her a place among Egypt’s early pioneers exploring biological control methods in Plant Pathology. Her academic excellence laid the groundwork for decades of scientific contribution, particularly in understanding nematode interactions and eco-friendly control strategies. Through education and research, she solidified her identity as a passionate academic whose legacy in Plant Pathology began in lecture halls but would soon extend to global symposiums.

🧪 PROFESSIONAL ENDEAVORS AND SCIENTIFIC MISSIONS

Prof. Hoda’s professional trajectory within the National Research Center (NRC) of Egypt exemplifies her dedication to Plant Pathology through practical research, academic service, and institutional leadership. Beginning as a Technical Specialist in 1974, she rose through the ranks to become a Research Professor and eventually Head of the Plant Pathology Department. Her work at NRC was instrumental in developing Egypt’s sustainable agriculture framework, particularly in nematode control strategies. Her six-month scientific mission to Brigham Young University in the United States expanded her global perspective, enriching her research methodologies in Plant Pathology. Her involvement with the Pesticides Committee of the Ministry of Agriculture further showcased her advisory role in translating science into policy. Through years of dedicated lab and field research, she tackled soil-borne pathogens, biocontrol agents, and crop disease complexes that threatened Egypt’s agricultural productivity. Each professional step reinforced her contributions to Plant Pathology, as she continuously integrated microbial, ecological, and biotechnological approaches into national research projects. Prof. Hoda’s multifaceted role included supervision of theses, mentoring early-career researchers, and coordinating multidisciplinary collaborations, all while strengthening Egypt’s scientific foundation in Plant Pathology. Her career is a testament to applied science serving real-world agricultural challenges.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS IN PLANT PATHOLOGY

Prof. Hoda Hussein Amin Mohamed’s research career is defined by her relentless pursuit of solutions to agricultural nematode infestations through the lens of Plant Pathology. With over 45 peer-reviewed publications, she has contributed profoundly to understanding and mitigating root-knot nematodes such as Meloidogyne incognita and Rotylenchulus reniformis. Her research harnessed microbial biocontrol agents including genetically improved rhizobacteria, Pseudomonas fluorescens, and various biocomplexes, highlighting the value of environmentally friendly solutions in Plant Pathology. Her projects explored the synergistic effects of biofertilizers, composts, and plant extracts, developing integrated management systems for sustainable farming. Notable research includes evaluating resistance in Solanaceae plants under greenhouse and field conditions, and applying biotechnology to induce plant defense mechanisms. As Principal Investigator on several national projects, she has advanced the application of molecular tools and biotechnological innovations in Plant Pathology. From the use of callus tissue cultures of marigold for nematode suppression to deploying enzyme-inducing bacterial treatments, her scientific portfolio is both pioneering and comprehensive. Her research focus not only reflects her depth in Plant Pathology but also her commitment to ecological integrity, sustainable agriculture, and science-based policy for managing crop health in Egypt and beyond.

🏆 ACCOLADES AND RECOGNITION IN SCIENTIFIC EXCELLENCE

Throughout her illustrious career, Prof. Hoda Hussein Amin Mohamed has earned wide recognition for her unwavering commitment to the advancement of Plant Pathology. Her leadership as Head of the Plant Pathology Department at the National Research Center and her pivotal role in national research initiatives are reflective of her excellence. She has been repeatedly called upon to participate in expert committees and symposiums, including national pesticide evaluation panels and seminars on biological control, illustrating her influence in shaping Egypt’s agricultural policies. Her participation and paper presentations in prominent international conferences such as the Syrian-Egyptian Agricultural Forum and the Arab Conference on Plant Protection highlight her as a respected voice in global Plant Pathology circles. She is also a valued member of several prestigious scientific societies, including the Egyptian Society of Plant Pathology and the Arab Society for Plant Protection. Her accolades are not limited to formal recognition but are deeply embedded in the sustainable impacts of her projects, the respect of her peers, and the generations of researchers she has mentored. Prof. Hoda’s accolades affirm her as not only a scientific authority but a dedicated advocate for ethical and sustainable Plant Pathology practices across the Arab world and internationally.

🌍 IMPACT AND INFLUENCE ON AGRICULTURAL SYSTEMS

Prof. Hoda’s work in Plant Pathology has had transformative effects on Egyptian agriculture, particularly in developing non-chemical, eco-friendly strategies for pest management. Her research on the biological control of nematodes has led to significant advancements in crop yield, soil health, and integrated pest management strategies. The influence of her studies reaches from laboratories to farmlands, improving conditions for Egyptian farmers and contributing to national food security. Her guidance on biocontrol methods has empowered agricultural policies to embrace sustainability and reduce reliance on synthetic chemicals. By focusing on crops of high economic value—such as tomatoes, potatoes, eggplants, and peanuts—her research in Plant Pathology has enhanced productivity and resilience in staple food systems. Moreover, her role in major national and international collaborations has shaped regional agricultural strategies and shared Egyptian innovations with the broader scientific community. Through mentoring, supervising dissertations, and participating in seminars, she has shaped the intellectual fabric of Plant Pathology in Egypt. Her work not only influences policy and practice but fosters a culture of environmentally conscious research. Prof. Hoda’s legacy in Plant Pathology is built upon both academic rigor and tangible societal benefit—proving that impactful research can transform not just knowledge, but lives.

🔮 LEGACY AND FUTURE CONTRIBUTIONS IN PLANT PATHOLOGY

Prof. Hoda Hussein Amin Mohamed’s legacy in Plant Pathology continues to inspire future generations of scientists dedicated to sustainable agriculture and ecological resilience. As an Emeritus Research Professor, her ongoing mentorship, critical reviews, and advisory roles keep her at the heart of Egypt’s scientific development. Her legacy lies not only in her prolific research but also in the networks she built across academic, governmental, and farming communities. The future of Plant Pathology in Egypt is brighter because of her foundational work on biological control methods, microbial applications, and biotechnological advancements for nematode suppression. By bridging traditional knowledge with future-forward technologies, Prof. Hoda has left a blueprint for environmentally aligned research. Young scientists now build upon her methodologies, exploring gene editing, advanced microbial ecology, and systems-based pest management rooted in her foundational principles. Her emphasis on mentoring ensures the continuity of ethical and impactful Plant Pathology research. Prof. Hoda’s legacy is not confined to publications or awards—it lives in the fields restored by her innovations and in the scientific minds she continues to shape. As agriculture faces climate-driven challenges, her contributions to Plant Pathology remain not only relevant but essential to a sustainable global food future.

NOTABLE PUBLICATION

  • Title: Effects and mode of action of some plant extracts on certain plant parasitic nematodes
    Authors: A.M. Korayem, S.A. Hasabo, H.H. Ameen
    Journal: Anzeiger für Schädlingskunde, Pflanzenschutz, Umweltschutz, Volume 66 (2), Pages 32–36 (1993)

 

  • Title: Improving the nematicidal potential of Bacillus amyloliquefaciens and Lysinibacillus sphaericus against the root-knot nematode Meloidogyne incognita using protoplast fusion
    Authors: M.S. Abdel-Salam, H.H. Ameen, G.M. Soliman, U.S. Elkelany, A.M. Asar
    Journal: Egyptian Journal of Biological Pest Control, Volume 28 (1), Article 1–6 (2018)

 

  • Title: Efficacy of integrated microorganisms in controlling root-knot nematode Meloidogyne javanica infecting peanut plants under field conditions
    Authors: H.A. Osman, H.H. Ameen, M. Mohamed, U.S. Elkelany
    Journal: Bulletin of the National Research Centre, Volume 44 (1), Article 134 (2020)

 

  • Title: In vitro evaluation of some isolated bacteria against the plant parasite nematode Meloidogyne incognita
    Authors: G.M. Soliman, H.H. Ameen, S.M. Abdel-Aziz, G.M. El-Sayed
    Journal: Bulletin of the National Research Centre, Volume 43 (1), Article 171 (2019)

 

  • Title: Field control of Meloidogyne incognita and root rot disease infecting eggplant using nematicide, fertilizers, and microbial agents
    Authors: H.A. Osman, H.H. Ameen, M. Mohamed, R. El-Mohamedy, U.S. Elkelany
    Journal: Egyptian Journal of Biological Pest Control, Volume 28 (1), Article 40 (2018)